[The best of 2001. Thrombosis].
Although it is impossible to recall all the new developments of the year 2001 regarding thrombosis, we have selected certain results: several, with although "negative" results, are highly interesting because they contradict preliminary studies which could have predicted therapeutic perspectives that would considerably alter the management of a common and serious illness. In this sense, they remind us that the large randomised studies (RCT) remain the necessary and indispensable tool for validating a large scale therapy: others, because they come within the logic of certain earlier results, and in this sense it is good for a clinician to see that a certain logic still exists in cardiology; others again, because they define a certainly real benefit, but whose limits of applicability could sometimes escape clinicians.
Ferrari
E
E
Service de cardiologie, hôpital Pasteur, 30, avenue de la Voie romaine, 06002 Nice.
D006801:Humans; D012307:Risk Factors; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology